Ardelyx Presents Positive Data Further Supporting Efficacy and Safety of XPHOZAH® (tenapanor) at National Kidney Foundation 2023 Spring Clinical Meetings
Three posters support the important role that XPHOZAH, a novel phosphate absorption inhibitor, could potentially play in the treatment of hyperphosphatemia XPHOZAH consistently lowered serum... | April 12, 2023
United States Fosun Pharma Laura Williams Exchange Commission National Kidney Foundation Exchange Commission On
Source: marketscreener.com